DELIVERY DEVICE WITH A CONNECTOR HAVING DISPLACEABLE PORTIONS
20190151551 ยท 2019-05-23
Inventors
Cpc classification
A61M5/31528
HUMAN NECESSITIES
A61M5/20
HUMAN NECESSITIES
A61M5/2422
HUMAN NECESSITIES
A61M5/24
HUMAN NECESSITIES
A61M5/2459
HUMAN NECESSITIES
International classification
A61M5/24
HUMAN NECESSITIES
A61M5/315
HUMAN NECESSITIES
Abstract
A delivery device for delivering a medicament to a patient includes a cartridge disposable within a housing having a first end sealed by a septum and a second open end longitudinally opposed to the first end and defining a cartridge volume for holding the medicament. A stopper is at least partially disposed within the cartridge volume and displaceable within the cartridge volume to eject the medicament from the cartridge through the septum. A driving assembly connects to the stopper having a rotatable portion cooperatively engaged to an extendable portion such that rotation of the rotatable portion causes axial translation of the extendable portion and a connector assembly has a first connector portion connected to the extendable portion and a second connector portion connected to the stopper, the first connector portion and second connector portion are rotationally locked and axially displaceable relative to one another.
Claims
1. A delivery device for delivering a medicament to a patient, comprising: a cartridge disposable within a housing having a first end sealed by a septum and a second open end longitudinally opposed to the first end and defining a cartridge volume for holding the medicament; a stopper at least partially disposed within the cartridge volume and displaceable within the cartridge volume to eject the medicament from the cartridge through the septum; a driving assembly connected to the stopper having a rotatable portion cooperatively engaged to an extendable portion such that rotation of the rotatable portion causes axial translation of the extendable portion; and a connector assembly having a first connector portion connected to the extendable portion and a second connector portion connected to the stopper, the first connector portion and second connector portion being rotationally locked and axially displaceable relative to one another.
2. The delivery device of claim 1, wherein the first connector portion and second connector portion are axially slideable relative to one another.
3. The delivery device of claim 2, wherein one of the first connector portion and second connector portion has at least one locking groove formed therein and the other one of the first connector portion and second connector portion has at least one locking protrusion disposed in the at least one locking groove to rotationally lock the first connector portion and second connector portion.
4. The delivery device of claim 2, wherein one of the first connector portion and second connector portion has at least one sliding slot formed therein and the other one of the first connector portion and second connector portion has at least one sliding protrusion slideably held within the at least one sliding slot.
5. The delivery device of claim 4, wherein the at least one sliding protrusion includes a chamfer.
6. The delivery device of claim 1, wherein the first connector portion and second connector portion are telescopically connected to one another.
7. The delivery device of claim 1, wherein the first connector portion and second connector portion axially displace relative to one another when an axial load is applied to at least one of the driving assembly and the cartridge.
8. The delivery device of claim 1, wherein the connector assembly prevents pressurization of the medicament when a gap between the driving assembly and the cartridge closes.
9. The delivery device of claim 1, further comprising a housing that houses the cartridge and driving assembly.
10. A connector assembly for connecting a stopper to a driving assembly in a delivery device, comprising: a first connector portion for connecting to the driving assembly; and a second connector portion for connecting to the stopper rotationally locked to the first connector portion and axially displaceable relative to the first connector.
11. The connector assembly of claim 10, wherein the first connector portion and second connector portion are axially slideable relative to one another.
12. The connector assembly of claim 11, wherein one of the first connector portion and second connector portion has at least one locking groove formed therein and the other one of the first connector portion and second connector portion has at least one locking protrusion disposed in the at least one locking groove to rotationally lock the first connector portion and second connector.
13. The connector assembly of claim 11, wherein one of the first connector portion and second connector portion has at least one sliding slot formed therein and the other one of the first connector portion and second connector portion has at least one sliding protrusion slideably held within the at least one sliding slot.
14. The connector assembly of claim 13, wherein the at least one sliding protrusion includes a chamfer
15. The connector assembly of claim 10, wherein the first connector portion and second connector portion are telescopically connected to one another.
Description
BRIEF DESCRIPTION OF THE FIGURES
[0005] The foregoing and other objects, features and advantages of the exemplary embodiments will be more fully understood from the following description when read together with the accompanying drawings, in which:
[0006]
[0007]
[0008]
[0009]
[0010]
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
[0020]
DETAILED DESCRIPTION
[0021] The present disclosure provides delivery devices, components thereof, and methods for injecting a medicament into a patient.
[0022] The apparatus and methods presented herein can be used for injecting a variety of medicaments into a patient. In one embodiment, the delivery device can be configured in the form of a drug pump, i.e., a pump for infusing medicaments into a patient through a cannula. In some embodiments, the drug pump can be an infusion pump configured to deliver the medicament in a cartridge over a prolonged time period greater than one minute. In other exemplary embodiments, the delivery device can be configured in the form of an automatic injector, i.e., an injection device that automatically injects medicament into a patient upon activation. In some embodiments, the automatic injector can include one or more biasing members, such as springs, that are activated to deploy a needle and depress a plunger of the injector to carry out the automatic injection. In some embodiments, the automatic injector can be a wearable autoinjector, such as an on body delivery system that may adhere to the skin of the patient.
[0023] As used herein, the term medicament refers to a composition intended for use in medical diagnosis, cure, treatment, or prevention of disease. A medicament may be a therapeutic agent or a combination of therapeutic agents. A medicament may include a therapeutic protein, for example, a peptide or antibody, or antigen-binding portion thereof. A medicament may include an anesthetic, steroid, and/or any other therapeutic agent(s). In one embodiment, a medicament represents a mixture of two or even more pharmacologically active agents. In some embodiments, the medicament is a liquid therapeutic agent which includes one or more biological agents, such as a protein or antibody. In one exemplary embodiment, the medicament may be insulin for infusion to manage diabetes.
[0024] Referring now to the drawings, and more particularly to
[0025] The stopper 120 is disposed within the cartridge volume 111 and is axially displaceable along the cartridge longitudinal axis CLA to eject the medicament within the cartridge volume 111 from the cartridge 110. The stopper 120 may be formed of an elastomer and have a plunger portion 121 defining a first end of the stopper 120 closer to the first end 112 of the cartridge 110. The plunger portion 121, as can be seen, engages an interior surface 116 defining the boundary of the cartridge volume 111 so the plunger portion 121 can eject medicament from the cartridge 110 through the septum 113 as the stopper 120 axially displaces toward the first end 112 of the cartridge 110. The stopper 120 can also include another annular seal 122 to further guarantee sterility of the contents of the cartridge 110 and resist relative rotation between the stopper 120 and the cartridge 110.
[0026] A driving assembly 130 is connected to the stopper 120 to axially displace the stopper 120 within the cartridge volume 111 and eject medicament from the cartridge 110 through the septum 113. The driving assembly 130 can include a rotatable portion 131 having a gear ring 132 and an extendable portion 133 (best seen in
[0027] Referring now to
[0028] As is known, it is critical that proper doses of medicament are delivered to a patient in order to ensure efficacy. One problem that may occur with the delivery assembly 100, and referring now to
[0029] If there is a gap between the gear ring 132 and the cartridge 110, the axial load on the driving assembly 130 must be transmitted to the cartridge 110 through the interface of the stopper 120 and the cartridge 110, which is resisted only by the friction between these two parts. It is highly likely that the applied force exceeds the frictional force and so the stopper 120 moves towards the septum 113 until the gear ring 132 contacts the cartridge 110, which, when the medicament in the cartridge 110 is a fluid, pressurizes the fluid medicament of the cartridge 110. As the septum 113 is pierced and connected to a fluid delivery path, such as a fluid delivery line connected to a delivery needle, in the same action, the higher pressure inside the cartridge 110 causes the fluid medicament to flow into the fluid path and out of the delivery needle before the needle has penetrated the skin of the patient and is therefore wasted. Further, a user may believe that there is a problem with the device upon noticing the wasted fluid delivered through the fluid path. For a 2 mm movement of the stopper 120, and with a cartridge inside diameter ID of 12.27 mm, a volume of up to 0.236 mL can be lost, which can represent roughly 10% of the medicament volume. This, in turn, means that the cartridge 110 has to be over-filled by a similar volume to compensate for the potential loss, and also that the accuracy of the delivered dose is compromised by the volume of the over-fill because it may or may not be delivered, depending on the size of the gap G between the gear ring 132 and the cartridge 110 before use, and whether or not the stopper friction is overcome during loading of the cartridge 110.
[0030] Having identified the previously described issue with the delivery assembly 100 shown in
[0031] Referring specifically now to
[0032] Referring specifically now to
[0033] Referring specifically now to
[0034] The two connector portions 700, 800 can be coupled by inserting the main cylindrical portion 710 of the connector 700 into the sliding portion 820 of the second connector portion 800 so that the locking splines 815A, 815B of the second connector portion 800 engage with the locking grooves 711A, 711B of the first connector portion 700. The sliding tabs 712A, 712B of the first connector portion 700 can deflect radially inwards elastically during insertion, driven by the interaction of the leading chamfers 713A, 713B acting on the inner surface 814 of the sliding portion 820 of the second connector portion 800, and then snap back out into their original position when they align with the sliding slots 812A, 812B in the sliding portion 820 of the second connector portion 800. At this point, surfaces of the sliding tabs 712A, 712B are presented to the inside surface of the slots 812A, 812B, distal to the threading 831 in such a manner that axial separation of the two connector portions 700, 800 is prevented by the engagement of these surfaces, as illustrated in
[0035] The distance by which the two connector portions 700, 800 can move axially relative to each other, i.e., the slot length SL, is arranged to be equal to the total tolerance of the stopper positioning. Thus, where the stopper positioning tolerance is 1 mm, the relative axial movement of the two connector portions 700, 800 is 2 mm Furthermore, the respective lengths L1, L2 of the two connector portions 700, 800 are arranged such that when the stopper 120 is at the limit of its position that is furthest from the second open end 114 of the cartridge 110, the connector assembly 1000 is in the extended position and the gear ring 132 is in contact with the cartridge 110. Thus also, when the stopper 120 is at the limit of its position that is nearest to the second open end 114 of the cartridge 110, the connector assembly 1000 is free to move from the extended position to the compressed position without transmission of any load to the stopper 120 because the gear ring 132 contacts the cartridge 110 at the same time that the compressed position of the connector assembly 1000 is achieved. This means that no compression of the fluid in the cartridge volume 111 occurs, therefore no loss of fluid when the cartridge 110 is connected to a fluid delivery path, and hence no requirement to over-fill the cartridge 100 as previously described. In this sense, the previously described connector assembly 1000 can counteract the effects of differing positions of the stopper 120 within the cartridge 110. Preventing the fluid loss due to pressurization not only prevents expensive medicaments, such as biologic medicaments, from being wasted, but can also increase the accuracy of the administered dose and prevent false-positive malfunction reports that occur when the user notices the medicament being wasted and believes there is a malfunction with the device.
[0036] Referring now to
[0037] While the previously described connector assembly 1000 has been particularly described and illustrated for use in delivery devices such as drug pumps, exemplary embodiments of connector assemblies formed in accordance with the present invention can be used in automatic injector devices. In some exemplary embodiments, the connector assembly can be used in addition to, or in place of, the actuation member or plunger of the automatic injector. When used in automatic injector devices, the connector assembly can also counteract the effects of tolerance stack up affecting the initial position of the plunger in order to reduce the need for over-filling, increase the accuracy of delivered doses, and prevent medicament being wasted prior to injection.
[0038] In describing exemplary embodiments, specific terminology is used for the sake of clarity. For purposes of description, each specific term is intended to at least include all technical and functional equivalents that operate in a similar manner to accomplish a similar purpose. Additionally, in some instances where a particular exemplary embodiment includes a plurality of system elements or method steps, those elements or steps may be replaced with a single element or step. Likewise, a single element or step to may be replaced with a plurality of elements or steps that serve the same purpose. Further, where parameters for various properties are specified herein for exemplary embodiments, those parameters may be adjusted up or down by 1/20th, 1/10.sup.th, th, rd, nd, and the like, or by rounded-off approximations thereof, unless otherwise specified. Moreover, while exemplary embodiments have been shown and described with references to particular embodiments thereof, those of ordinary skill in the art will understand that various substitutions and alterations in form and details may be made therein without departing from the scope of the invention. Further still, other aspects, functions and advantages are also within the scope of the invention.